Member Info for Shukan

Collaboration, License and Investment by Orgenesis for unique mouse model The Lab is paid for in shares of Hemogenyx

bid chaser still at it - hurry up and clear off will you

2.63 to sell £2.5K worth any other amounts no firm quote

I tweeted this earlier #HEMO @HemoGenyx Market Makers on a tweet from the lab made a market to 7p -today we have collaborations and we have verified data the market thinks it’s worth 2.5p - it makes a mockery of what Hemogenyx has achieved to date .

The lowest historical sale I have seen is 1.9p the highest 6.9p -

Not a cure - but can help up to 30% of patients waiting for bone marrow transplantation that previously would die without CDX- antibodies

Is this due to the company not having enough money to get through clinical trials etc?
NO- read the RNS,s on collaborations and the funding notes also ORGS video with the CEO

of course and now the tree starting to bud- they are funded partly by ORGS -

2.61 to sell - LOL

now watch for that licencing deal!!!

Before P trials - let’s see who’s in the game on licensing and the terms - this will reveal going forward VALIDATION OF THE TECH IS KEY HERE - that’s why licensing deal is a game changer for the company

tick up ? lets see

indeed any day now

indeed!

investment v current MC = BOOM

MM,s will grab all what’s on offer

Seller back at 2.41- LOL at this stage of the game

seller chasing the bid

added another 300,000 odd top up - they will take 578148 at 2.41p bodes well - upside incoming,

Indeed this is correct-